Cambridge Company Gets Boost From Hepatitis C Drug
BOSTON (CBS) – Shares of Cambridge-based Vertex went up about 12-percent Wednesday after regulators indicated that their potential drug for Hepatitis C was effective.
Lisa van der Pool of the Boston Business Journal reports.
